On Friday, August 21, 2026, France's anti-fraud watchdog DGCCRF and the health ministry's Directorate-General for Health (DGS) issued a joint national warning covering roughly 300,000 potentially unsafe condoms sold online, in shops and in pharmacies. The alert splits into two distinct failures. Lab inspections in physical retail found two condom products that carried the European CE conformity marking but were non-compliant anyway — one presenting a risk of bursting, the other found to have perforations. Around 260,000 units were pulled under recalls launched in late May and early August, per the health ministry.

Why It Matters

This is the sexual wellness category's version of a supply-chain audit, and it exposes two structural weaknesses at once. The first is that CE marking — the badge the entire European regulatory model rests on for condoms as Class IIb medical devices — is not self-enforcing. Two products carrying valid marks still failed physical testing, which means conformity assessment on paper and barrier integrity in practice can diverge. For a product whose entire value proposition is that it does not fail, that gap is the whole ballgame. The second is the marketplace channel. Thirty listings with no CE assessment and no French labeling reached French consumers through major online platforms, and it took a regulator, not the platforms' own compliance systems, to catch them. Sexual wellness brands have spent years pushing into mainstream e-commerce and pharmacy distribution as a destigmatisation strategy; this recall is a reminder that the same channels carry unvetted parallel imports that trade on category trust the legitimate brands built. For the industry, expect knock-on pressure on marketplace due diligence for barrier contraceptives specifically, and closer scrutiny of the batch-testing and traceability regimes brands can actually demonstrate. Notably, the one brand that spoke on the record — My Lubie — pulled a batch pre-emptively on its own analysis. In a category where the downside is measured in STIs and unintended pregnancies rather than returns, that instinct is likely to become the expected standard rather than a differentiator.

The second failure is a marketplace problem. The agencies identified roughly 30 condom lines listed on online marketplaces that lack the CE mark entirely and have never undergone any assessment against European standards. Most also lack French-language packaging. About 1,000 boxes — more than 40,000 individual condoms — had already sold, largely through what authorities characterised as Asian distributors. The platforms have agreed to delist the products.

France's Rappel Conso recall register names the brands involved: Friday Bae (Le Préservatif), Okamoto (the 003 and 002 lines), Sagami (Sagami Original 002, sold via Amazon), and My Lubie, whose products move through Amazon, pharmacies and retailers including Nuoo, Mademoiselle Bio, Monoprix, Ayanature and Passage du Désir. My Lubie chief executive Pierre Lagache told Reuters the recall involved a single batch that initially tested negatively, though follow-up analysis on the same batch showed conformity. "We are talking about a medical device: at the slightest doubt, we pull it from the market without waiting," he said, adding that My Lubie recalled the batch on its own initiative as a precaution and that no harm has been reported. Okamoto Industries and Friday Bae did not immediately respond to Reuters' requests for comment.

The consumer guidance is blunt and unusual for a product recall: anyone who used the affected condoms should get screened for sexually transmitted infections and take a pregnancy test in the event of a late period. Non-compliant condoms, the agencies noted, "pose serious risks to users' health and safety: sexually transmitted infections, unwanted pregnancies."

Sources

Update — 2026-08-25

{Initial entry — story first created.}